H D Kleber, M S Gold. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AnimalsAnti-Anxiety Agents/therapeutic useAntidepressive Agents, Tricyclic/therapeutic useAntipsychotic Agents/therapeutic useBenzodiazepinesDrug InteractionsDrug Therapy, CombinationHumansHypnotics and Sedatives/therapeutic useLithium/therapeutic useMethadone/administration & dosageMethadone/therapeutic useMonoamine Oxidase Inhibitors/therapeutic usePsychotropic Drugs/therapeutic useReceptors, Opioid/drug effectsSchizophrenia/complicationsSchizophrenia/drug therapySleep Initiation and Maintenance Disorders/complicationsSleep Initiation and Maintenance Disorders/drug therapySubstance-Related Disorders/complicationsSubstance-Related Disorders/rehabilitation
Substances: See more » Anti-Anxiety AgentsAntidepressive Agents, TricyclicAntipsychotic AgentsHypnotics and SedativesMonoamine Oxidase InhibitorsPsychotropic DrugsReceptors, OpioidBenzodiazepinesLithiumMethadone
Year: 1978 PMID: 33588 DOI: 10.1111/j.1749-6632.1978.tb16767.x
Source DB: PubMed Journal: Ann N Y Acad Sci ISSN: 0077-8923 Impact factor: 5.691